NVO Jan 2025 200.000 call
| Previous close | 24.56 |
| Open | 25.00 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 200.00 |
| Expiry date | 2025-01-17 |
| Day's range | 24.00 - 25.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 334 |
Globe NewswireNovo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 25 September 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 30 billion to be executed during a 12-month period beginning 1 February 2023. Under the programm
- Globe Newswire
Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and artificial intelligence
Collaboration will apply Valo’s Opal Computational Platform™ and real-world patient dataset to enable the discovery and development of novel cardiometabolic drug programmes Novo Nordisk licenses three preclinical drug discovery programmes in cardiovascular diseases discovered and developed by Valo using the Opal Computational Platform™ Valo will receive an upfront payment and a potential near-term milestone payment, totalling 60 million US dollars, and is eligible to receive milestone payments f
ZacksBeat the Market Like Zacks: Elementis, Novo Nordisk, Amgen in Focus
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
